Law ❯ Securities Law ❯ Class Action ❯ Investor Rights

Corporate Governance

Avantor Faces Shareholder Class Action Over Competition Disclosures as Lead-Plaintiff Deadline Nears

Investors have until December 29 to seek appointment to lead the case alleging the company downplayed competitive pressures.

Jasper Therapeutics Investors Face Lead Plaintiff Deadline in Securities Class Action

Synopsys Investors Face Dec. 30 Deadline to Seek Lead Role in Securities Class Action

MoonLake Investors Face Dec. 15 Deadline in Securities Suits Over Sonelokimab Claims

James Hardie Investors Face Dec. 23 Deadline to Seek Lead Role in Securities Suit Over Alleged Destocking Deception

Cytokinetics Faces Wave of Investor Lawsuits as Lead Plaintiff Deadline Nears

DexCom Faces Wave of Securities Class Actions Over FDA-Faulted CGM Changes

V.F. Corporation Investors Near Lead-Plaintiff Deadline in Vans Turnaround Securities Suits

MoonLake Investors Courted for Lead Role in SDNY Securities Case After SLK Trial Collapse

Quanex Faces Securities Class Action Over Tyman Mexico Disclosures as Lead‑Plaintiff Deadline Nears

LifeMD Securities Case Reaches Lead-Plaintiff Deadline as Firms Court Investors

Japan’s Big Three Banks Plan Joint Yen Stablecoin on MUFG’s Progmat

Law Firms Urge Jasper Therapeutics Investors to Seek Lead‑Plaintiff Role Before Nov. 18 Deadline

Charter Faces Securities Class Action Over ACP Disclosures in SDNY

Sept. 30 Lead‑Plaintiff Deadline Nears in Novo Nordisk Securities Case

Sable Offshore Investors Face Sept. 26 Deadline in Class Action Over Alleged Restart Misstatements

RxSight Securities Suit Nears Lead-Plaintiff Deadline After 38% Stock Plunge

Alto Neuroscience Investors Urged to Seek Lead Plaintiff Status by Sept. 19